StockNews.com Upgrades Acadia Healthcare (NASDAQ:ACHC) to “Hold”

Acadia Healthcare (NASDAQ:ACHC) was upgraded by equities researchers at StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday.

A number of other research analysts have also commented on ACHC. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. KeyCorp began coverage on shares of Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating for the company. Barclays reduced their price target on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research report on Monday, September 30th. Cantor Fitzgerald restated a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Finally, Royal Bank of Canada restated an “outperform” rating and set a $94.00 price target on shares of Acadia Healthcare in a research report on Friday, September 20th. Five equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $86.67.

Acadia Healthcare Trading Up 0.4 %

Shares of ACHC stock opened at $42.51 on Monday. The company’s fifty day simple moving average is $65.00 and its two-hundred day simple moving average is $67.55. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. Acadia Healthcare has a 1 year low of $41.42 and a 1 year high of $87.77. The stock has a market capitalization of $3.95 billion, a price-to-earnings ratio of 13.94, a PEG ratio of 1.33 and a beta of 1.33.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. During the same quarter in the previous year, the firm posted $0.91 EPS. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. GAMMA Investing LLC boosted its position in Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after buying an additional 241 shares during the period. Blue Trust Inc. boosted its position in Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after buying an additional 248 shares during the period. Commonwealth Equity Services LLC boosted its position in Acadia Healthcare by 3.5% during the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock valued at $513,000 after buying an additional 257 shares during the period. Atria Investments Inc boosted its position in Acadia Healthcare by 4.7% during the third quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock valued at $434,000 after buying an additional 308 shares during the period. Finally, Crossmark Global Holdings Inc. boosted its position in Acadia Healthcare by 6.6% during the third quarter. Crossmark Global Holdings Inc. now owns 7,077 shares of the company’s stock valued at $449,000 after buying an additional 440 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.